Work

P021 A phase 3, open-label study of tezacaftor/ivacaftor (TEZ/IVA) therapy: interim analysis of pooled safety, and efficacy in patients homozygous for F508del-CFTR

Year: 2018

Type: conference-abstract

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(18)30318-7

Authors: P. Flume, J. Lekstrom-Himes, R. Fischer Biner, C. Simard, D.G. Downey, H. Zhou, C.A. Owen, K. De Boeck

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2807635725

Cites:

Cited by: 4

Related to: 10